Wade Benton

Wade Benton joined CiVi Biopharma in May 2018 as vice president of clinical development. Wade has more than 20 years of experience in clinical research in the pharmaceutical industry, most recently as the chief executive officer and chairman of Eicos Sciences, a wholly-owned subsidiary of CiVi Biopharma.

Wade has successfully led medical and clinical teams in pulmonary arterial hypertension, chronic kidney disease and heart failure at Actelion and Relypsa.